This report provides a comprehensive analysis of the global Clinical Pathology AI Software market, which is projected to experience significant growth through 2032. Utilizing AI and machine learning to enhance diagnostic accuracy in tissue and fluid analysis, the market is driven by increasing demand for efficiency in hospitals, diagnostic centers, and research laboratories. The study evaluates key trends, competitive landscapes, and regional dynamics across the Americas, APAC, and Europe, segmented by cloud-based and on-premise deployment models.

Market Overview

Global Market Size and Forecast

The global Clinical Pathology AI Software market is predicted to grow from US$ 245 million in 2025 to US$ 476 million in 2032, representing a compound annual growth rate (CAGR) of 10.1% from 2026 to 2032.

Definition and Utility

Clinical Pathology AI Software refers to advanced software systems that utilize artificial intelligence (AI) and machine learning (ML) techniques to assist in the analysis, diagnosis, and management of diseases through the examination of tissue samples, blood, and other bodily fluids. This software is increasingly used in clinical pathology labs to enhance accuracy, efficiency, and diagnostic capabilities, thereby improving patient outcomes.

Regional Market Insights

• United States: The market for Clinical Pathology AI Software in the United States is estimated to experience growth from 2025 through 2032.
• China: The market for Clinical Pathology AI Software in China is estimated to experience growth from 2025 through 2032.
• Europe: The market for Clinical Pathology AI Software in Europe is estimated to experience growth from 2025 through 2032.

Report Scope and Methodology

Research Objectives

LPI (LP Information)' newest research report, the “Clinical Pathology AI Software Industry Forecast,” reviews total world Clinical Pathology AI Software sales in 2025 and provides a comprehensive analysis by region and market sector of projected Clinical Pathology AI Software sales for 2026 through 2032. With Clinical Pathology AI Software sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Pathology AI Software industry.

This Insight Report provides a comprehensive analysis of the global Clinical Pathology AI Software landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Clinical Pathology AI Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints to better understand their unique positions in an accelerating global market.

Market Dynamics and Analysis

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Clinical Pathology AI Software. It breaks down the forecast by Type, Application, Geography, and Market Size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global industry. The report presents a comprehensive overview, market shares, and growth opportunities categorized by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Cloud-Based
• On-Premise

By Application

• Hospital
• Diagnostic Centers
• Laboratories & Research Institutes

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Share and Key Players

Global key Clinical Pathology AI Software players include PathAI, Proscia, Aiforia, Deep Bio, and Hologic. In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Company Profiles

The following companies have been profiled based on inputs gathered from primary experts and an analysis of their coverage, product portfolio, and market penetration:

• PathAI
• Proscia
• Aiforia
• Deep Bio
• Hologic
• Dipath
• iDeepwise
• LBP
• F.Q pathtech
• CellaVision
• AIRA Matrix
• Syntropy
• Indica Labs
• DoMore Diagnostics
• Mindpeak
• Evidium

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Clinical Pathology AI Software Market Size (2021-2032)

    • 2.1.2 Clinical Pathology AI Software Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Clinical Pathology AI Software by Country/Region (2021, 2025 & 2032)

  • 2.2 Clinical Pathology AI Software Segment by Type

    • 2.2.1 Cloud-Based

    • 2.2.2 On-Premise

    • 2.2.3 Clinical Pathology AI Software Market Size by Type

      • 2.2.3.1 Clinical Pathology AI Software Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Clinical Pathology AI Software Market Size Market Share by Type (2021-2026)

  • 2.3 Clinical Pathology AI Software Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Diagnostic Centers

    • 2.3.3 Laboratories & Research Institutes

    • 2.3.4 Clinical Pathology AI Software Market Size by Application

      • 2.3.4.1 Clinical Pathology AI Software Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Clinical Pathology AI Software Market Size Market Share by Application (2021-2026)

• 3 Clinical Pathology AI Software Market Size by Player

  • 3.1 Clinical Pathology AI Software Market Size Market Share by Player

    • 3.1.1 Global Clinical Pathology AI Software Revenue by Player (2021-2026)

    • 3.1.2 Global Clinical Pathology AI Software Revenue Market Share by Player (2021-2026)

  • 3.2 Global Clinical Pathology AI Software Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Clinical Pathology AI Software by Region

  • 4.1 Clinical Pathology AI Software Market Size by Region (2021-2026)

  • 4.2 Global Clinical Pathology AI Software Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Clinical Pathology AI Software Market Size Growth (2021-2026)

  • 4.4 APAC Clinical Pathology AI Software Market Size Growth (2021-2026)

  • 4.5 Europe Clinical Pathology AI Software Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Clinical Pathology AI Software Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Clinical Pathology AI Software Market Size by Country (2021-2026)

  • 5.2 Americas Clinical Pathology AI Software Market Size by Type (2021-2026)

  • 5.3 Americas Clinical Pathology AI Software Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Clinical Pathology AI Software Market Size by Region (2021-2026)

  • 6.2 APAC Clinical Pathology AI Software Market Size by Type (2021-2026)

  • 6.3 APAC Clinical Pathology AI Software Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Clinical Pathology AI Software Market Size by Country (2021-2026)

  • 7.2 Europe Clinical Pathology AI Software Market Size by Type (2021-2026)

  • 7.3 Europe Clinical Pathology AI Software Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Clinical Pathology AI Software by Region (2021-2026)

  • 8.2 Middle East & Africa Clinical Pathology AI Software Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Clinical Pathology AI Software Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Clinical Pathology AI Software Market Forecast

  • 10.1 Global Clinical Pathology AI Software Forecast by Region (2027-2032)

    • 10.1.1 Global Clinical Pathology AI Software Forecast by Region (2027-2032)

    • 10.1.2 Americas Clinical Pathology AI Software Forecast

    • 10.1.3 APAC Clinical Pathology AI Software Forecast

    • 10.1.4 Europe Clinical Pathology AI Software Forecast

    • 10.1.5 Middle East & Africa Clinical Pathology AI Software Forecast

  • 10.2 Americas Clinical Pathology AI Software Forecast by Country (2027-2032)

    • 10.2.1 United States Market Clinical Pathology AI Software Forecast

    • 10.2.2 Canada Market Clinical Pathology AI Software Forecast

    • 10.2.3 Mexico Market Clinical Pathology AI Software Forecast

    • 10.2.4 Brazil Market Clinical Pathology AI Software Forecast

  • 10.3 APAC Clinical Pathology AI Software Forecast by Region (2027-2032)

    • 10.3.1 China Clinical Pathology AI Software Market Forecast

    • 10.3.2 Japan Market Clinical Pathology AI Software Forecast

    • 10.3.3 Korea Market Clinical Pathology AI Software Forecast

    • 10.3.4 Southeast Asia Market Clinical Pathology AI Software Forecast

    • 10.3.5 India Market Clinical Pathology AI Software Forecast

    • 10.3.6 Australia Market Clinical Pathology AI Software Forecast

  • 10.4 Europe Clinical Pathology AI Software Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Clinical Pathology AI Software Forecast

    • 10.4.2 France Market Clinical Pathology AI Software Forecast

    • 10.4.3 UK Market Clinical Pathology AI Software Forecast

    • 10.4.4 Italy Market Clinical Pathology AI Software Forecast

    • 10.4.5 Russia Market Clinical Pathology AI Software Forecast

  • 10.5 Middle East & Africa Clinical Pathology AI Software Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Clinical Pathology AI Software Forecast

    • 10.5.2 South Africa Market Clinical Pathology AI Software Forecast

    • 10.5.3 Israel Market Clinical Pathology AI Software Forecast

    • 10.5.4 Turkey Market Clinical Pathology AI Software Forecast

  • 10.6 Global Clinical Pathology AI Software Forecast by Type (2027-2032)

  • 10.7 Global Clinical Pathology AI Software Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Clinical Pathology AI Software Forecast

• 11 Key Players Analysis

  • 11.1 PathAI

    • 11.1.1 PathAI Company Information

    • 11.1.2 PathAI Clinical Pathology AI Software Product Offered

    • 11.1.3 PathAI Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 PathAI Main Business Overview

    • 11.1.5 PathAI Latest Developments

  • 11.2 Proscia

    • 11.2.1 Proscia Company Information

    • 11.2.2 Proscia Clinical Pathology AI Software Product Offered

    • 11.2.3 Proscia Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Proscia Main Business Overview

    • 11.2.5 Proscia Latest Developments

  • 11.3 Aiforia

    • 11.3.1 Aiforia Company Information

    • 11.3.2 Aiforia Clinical Pathology AI Software Product Offered

    • 11.3.3 Aiforia Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Aiforia Main Business Overview

    • 11.3.5 Aiforia Latest Developments

  • 11.4 Deep Bio

    • 11.4.1 Deep Bio Company Information

    • 11.4.2 Deep Bio Clinical Pathology AI Software Product Offered

    • 11.4.3 Deep Bio Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Deep Bio Main Business Overview

    • 11.4.5 Deep Bio Latest Developments

  • 11.5 Hologic

    • 11.5.1 Hologic Company Information

    • 11.5.2 Hologic Clinical Pathology AI Software Product Offered

    • 11.5.3 Hologic Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Hologic Main Business Overview

    • 11.5.5 Hologic Latest Developments

  • 11.6 Dipath

    • 11.6.1 Dipath Company Information

    • 11.6.2 Dipath Clinical Pathology AI Software Product Offered

    • 11.6.3 Dipath Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Dipath Main Business Overview

    • 11.6.5 Dipath Latest Developments

  • 11.7 iDeepwise

    • 11.7.1 iDeepwise Company Information

    • 11.7.2 iDeepwise Clinical Pathology AI Software Product Offered

    • 11.7.3 iDeepwise Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 iDeepwise Main Business Overview

    • 11.7.5 iDeepwise Latest Developments

  • 11.8 LBP

    • 11.8.1 LBP Company Information

    • 11.8.2 LBP Clinical Pathology AI Software Product Offered

    • 11.8.3 LBP Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 LBP Main Business Overview

    • 11.8.5 LBP Latest Developments

  • 11.9 F.Q pathtech

    • 11.9.1 F.Q pathtech Company Information

    • 11.9.2 F.Q pathtech Clinical Pathology AI Software Product Offered

    • 11.9.3 F.Q pathtech Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 F.Q pathtech Main Business Overview

    • 11.9.5 F.Q pathtech Latest Developments

  • 11.10 CellaVision

    • 11.10.1 CellaVision Company Information

    • 11.10.2 CellaVision Clinical Pathology AI Software Product Offered

    • 11.10.3 CellaVision Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 CellaVision Main Business Overview

    • 11.10.5 CellaVision Latest Developments

  • 11.11 AIRA Matrix

    • 11.11.1 AIRA Matrix Company Information

    • 11.11.2 AIRA Matrix Clinical Pathology AI Software Product Offered

    • 11.11.3 AIRA Matrix Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 AIRA Matrix Main Business Overview

    • 11.11.5 AIRA Matrix Latest Developments

  • 11.12 Syntropy

    • 11.12.1 Syntropy Company Information

    • 11.12.2 Syntropy Clinical Pathology AI Software Product Offered

    • 11.12.3 Syntropy Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Syntropy Main Business Overview

    • 11.12.5 Syntropy Latest Developments

  • 11.13 Indica Labs

    • 11.13.1 Indica Labs Company Information

    • 11.13.2 Indica Labs Clinical Pathology AI Software Product Offered

    • 11.13.3 Indica Labs Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Indica Labs Main Business Overview

    • 11.13.5 Indica Labs Latest Developments

  • 11.14 DoMore Diagnostics

    • 11.14.1 DoMore Diagnostics Company Information

    • 11.14.2 DoMore Diagnostics Clinical Pathology AI Software Product Offered

    • 11.14.3 DoMore Diagnostics Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 DoMore Diagnostics Main Business Overview

    • 11.14.5 DoMore Diagnostics Latest Developments

  • 11.15 Mindpeak

    • 11.15.1 Mindpeak Company Information

    • 11.15.2 Mindpeak Clinical Pathology AI Software Product Offered

    • 11.15.3 Mindpeak Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Mindpeak Main Business Overview

    • 11.15.5 Mindpeak Latest Developments

  • 11.16 Evidium

    • 11.16.1 Evidium Company Information

    • 11.16.2 Evidium Clinical Pathology AI Software Product Offered

    • 11.16.3 Evidium Clinical Pathology AI Software Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Evidium Main Business Overview

    • 11.16.5 Evidium Latest Developments

• 12 Research Findings and Conclusion